Sort   by:  
 Page size 
Targeting mutant KRAS signaling pathways continues to attract attention as a therapeutic strategy for KRAS-driven tumors. In this study, we exploited the power of the CRISPR-Cas9 system to identify genes affecting the tumor xenograft growth of human mutant KRAS (KRASMUT) colorectal cancer...

Background

Immune checkpoint therapy (ICT) provides durable responses in select cancer patients, yet resistance remains a significant challenge, prompting the exploration of underlying molecular mechanisms. Tyrosylprotein sulfotransferase-2 (TPST2), known for its role in protein tyrosine O-s...
The protein(s) larger than 100 kDa in conditioned medium from lung cancer cell lines activated microglia. The >100 kDa fraction of conditioned medium from H460, H1299, H2030, or H292 cells was collected. Proteins present in the conditioned medium were analyzed by LC-MS/MS.
ORGANISM(S): Homo sapiens (Human) 
2023-02-17 | PXD038129 | Pride
A genome-wide CRISPR/Cas9-based functional screen uncovers the KLF4-Survivin/BIRC5 signaling pathway as a key regulator of cell fate following endoplasmic reticulum stress: Implications for tumor growth and therapeutic targeting
Sort   by:  
 Page size